Autologous Patch Healing vs. Secondary Intention Healing After Mohs Micrographic Surgery
NCT ID: NCT05170035
Last Updated: 2023-03-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
26 participants
INTERVENTIONAL
2022-02-01
2024-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mohs Versus Traditional Surgery - Basal-Cell Carcinomas (BCC)
NCT00699829
Recurrence Rate and Esthetic Outcome After Excision of Basal Cell Carcinomas Excluded From Trial NCT00515970
NCT00639652
Curettage Versus Excision in Nodular and Superficial Basal Cell Carcinomas
NCT00515970
Palliative Treatment of Ulcerated Cutaneous Metastases: Trial Between Electrochemotherapy and Radiotherapy
NCT00918593
Complications and Recurrences After Mohs Micrographic Surgery and Slow Mohs
NCT06014619
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MMS + Autologous patch
Mohs micrographic surgery + Autologus patch formed from 18 ml venous blood sample collected from the patient + polymycin-terramycin B ointment and a Jelonet applied on top of the patch.
MMS + Autologous patch
A patch of consisting of platelets, leucocytes and fibrin, formed by the patients own blood sample.
MMS + Secondary intention healing
Mohs micropgraphic surgery + Polymycin-terramycin B ointment + dry wound dressing
MMS and secondary intention healing
Mohs micrographic surgery (standard of care) (wounds will heal by secondary intention healing)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MMS + Autologous patch
A patch of consisting of platelets, leucocytes and fibrin, formed by the patients own blood sample.
MMS and secondary intention healing
Mohs micrographic surgery (standard of care) (wounds will heal by secondary intention healing)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Presenting relevant medical record report at study initiation
3. Written informed consent obtained from subject
4. Understanding of investigation procedures and willingness to abide to all procedures during the course of the investigation.
Exclusion Criteria
2. Significant history or current evidence of a medical, psychological or other disorder that, in the investigator's opinion, would preclude enrollment into the study.
3. Pregnant or breast feeding
4. Unable to follow the outlined study protocol
5. Participation in other studies at the same time that may affect the wound healing.
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Benzon Foundation
UNKNOWN
Bispebjerg Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Katrine Elisabeth Karmisholt
MD, Chief Consultant, Ass.Prof., PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bispebjerg Hospital
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Autologous Patch-project
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.